 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - 4D Molecular Therapeutics Inc. (FDMT)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-12-15 Purchase | 2020-12-17 5:39 pm | 4D Molecular Therapeutics Inc. | FDMT | YAO TONY DUNG LING Director | 425,000 | $23 | $9,775,000 | 1,060,880 (Indirect Direct) | View |
| 2020-12-15 Purchase | 2020-12-17 5:40 pm | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz See Remarks | 4,347 | $23 | $99,981 | 4,347 (Direct) | View |
| 2020-12-15 Purchase | 2020-12-17 5:40 pm | 4D Molecular Therapeutics Inc. | FDMT | MILLIGAN JOHN F Director | 100,000 | $23 | $2,300,000 | 100,000 (Indirect) | View |
| 2020-12-15 Purchase | 2020-12-17 9:15 pm | 4D Molecular Therapeutics Inc. | FDMT | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 1,100,000 | $23 | $25,300,000 | 3,937,914 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-12-15 Conversion | 2020-12-17 5:39 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | YAO TONY DUNG LING Director | 2,864 | $0 | 2,864 (Direct) | View |
| 2020-12-15 Conversion | 2020-12-17 5:39 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | YAO TONY DUNG LING Director | 455,326 | $0 | 455,326 (Indirect) | View |
| 2020-12-15 Conversion | 2020-12-17 5:39 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | YAO TONY DUNG LING Director | 180,554 | $0 | 635,880 (Indirect) | View |
| 2020-12-15 Conversion | 2020-12-17 5:39 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | YAO TONY DUNG LING Director | 2,864 | $0 | 0 (Direct) | View |
| 2020-12-15 Conversion | 2020-12-17 5:39 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | YAO TONY DUNG LING Director | 455,326 | $0 | 0 (Indirect) | View |
| 2020-12-15 Conversion | 2020-12-17 5:39 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | YAO TONY DUNG LING Director | 180,554 | $0 | 0 (Indirect) | View |
| 2020-12-15 Conversion | 2020-12-17 9:15 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 2,004,581 | $0 | 2,004,581 (Indirect) | View |
| 2020-12-15 Conversion | 2020-12-17 9:15 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 833,333 | $0 | 2,837,914 (Indirect) | View |
| 2020-12-15 Conversion | 2020-12-17 9:15 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 2,004,581 | $0 | 0 (Indirect) | View |
| 2020-12-15 Conversion | 2020-12-17 9:15 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 833,333 | $0 | 0 (Indirect) | View |
| 2021-03-08 Option Award | 2021-03-10 4:04 pm | N/A 2031-03-07 | 4D Molecular Therapeutics Inc. | FDMT | Moretti August J See Remarks | 70,000 | $0 | 70,000 (Direct) | View |
| 2021-03-08 Option Award | 2021-03-10 4:05 pm | N/A 2031-03-07 | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Director 10% Owner | 150,000 | $0 | 150,000 (Direct) | View |
| 2021-03-08 Option Award | 2021-03-10 4:06 pm | N/A 2031-03-07 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz See Remarks | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-04-12 Exercise | 2021-04-14 4:32 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Moretti August J CFO | 1,000 | $9.41 | 2,000 (Direct) | View |
| 2021-04-12 Exercise | 2021-04-14 4:32 pm | N/A 2029-03-19 | 4D Molecular Therapeutics Inc. | FDMT | Moretti August J CFO | 1,000 | $0 | 223,060 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 8:30 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | GRAY SUSANNAH Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 8:31 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | Tomasello Shawn Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 8:32 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | Miller-Rich Nancy Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 8:33 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | MILLIGAN JOHN F Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 8:33 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | MILLIGAN JOHN F Director | 11,250 | $0 | 11,250 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 8:33 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | Chacko Jacob Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 8:34 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | SCHAFFER DAVID Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 8:36 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | THEUER CHARLES Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-09 8:28 pm | N/A 2031-06-06 | 4D Molecular Therapeutics Inc. | FDMT | Zimmermann Carolyne Chief Business Officer | 60,000 | $0 | 60,000 (Direct) | View |